Medical News

RSS

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2014.

29 Sep 2014

Aptose joins Beat AML research collaboration

Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.

29 Sep 2014

New AliveECG app provides patients with free real-time AF detection in ECG recordings

AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in ECG recordings using its new FDA-cleared algorithm.

29 Sep 2014

Survey: Many patients not always well informed about treatment options

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

29 Sep 2014

Report: Too few staff to care for children admitted to intensive care units

More children than ever are being admitted to intensive care units in England and Wales but there are fewer staff per bed available to cope with the increase, according to a new report published jointly by the University of Leeds and University of Leicester.

29 Sep 2014

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

Myriad Genetics, Inc. today announced that its Tumor BRACAnalysis CDx- companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in women with ovarian cancer. Data from this new study were presented at the 2014 European Society for Medical Oncology annual meeting in Madrid, Spain.

29 Sep 2014

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.

29 Sep 2014

Scientists reveal that human brain can trigger random behavior

Many of the choices we make are informed by experiences we've had in the past. But occasionally we're better off abandoning those lessons and exploring a new situation unfettered by past experiences.

29 Sep 2014

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.

29 Sep 2014

Research points to remote monitoring as offering way to improve patient care

An aging population and an increased incidence of debilitating illnesses such as Parkinson's and Alzheimer's disease means there is pressure on technology to offer assistance with healthcare - monitoring and treatment. Research published in the International Journal of Ad Hoc and Ubiquitous Computing points to remote monitoring as offering a way to improve patient care and even accelerate medical research.

29 Sep 2014

Early detection of cancers on the horizon with supersensitive nanodevice

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville in collaboration with The Joint School of Nanoscience and Nanoengineering in Greensboro, NC.

29 Sep 2014

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Scientists have discovered a previously unknown mechanism by which estrogen prepares cells to divide, grow and, in the case of estrogen-positive breast cancers, resist cancer drugs. The researchers say the work reveals new targets for breast cancer therapy and will help doctors predict which patients need the most aggressive treatment.

29 Sep 2014

Coffee consumption associated with increase in life years, reduction in healthcare costs

Xcenda, the strategic consulting arm of AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution service companies, recently conducted the first-ever health economic analysis on coffee consumption.

29 Sep 2014

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized.

29 Sep 2014

New report urges nations to adopt improved data collection efforts for community health workers

A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.

29 Sep 2014

Perfectionists may be at increased risk of suicide, says York University psychology professor

Perfectionism is a bigger risk factor in suicide than we may think, says York University Psychology Professor Gordon Flett, calling for closer attention to its potential destructiveness, adding that clinical guidelines should include perfectionism as a separate factor for suicide risk assessment and intervention.

29 Sep 2014

Researchers create new Cas9 animal model for in vivo genome editing experiments

Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system for in vivo genome editing experiments.

29 Sep 2014

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines.

29 Sep 2014

Lung-MAP, ALCHEMIST clinical trials offer innovative study designs for lung cancer patients

The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.

29 Sep 2014

Medical News

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Aptose joins Beat AML research collaboration

New AliveECG app provides patients with free real-time AF detection in ECG recordings

Survey: Many patients not always well informed about treatment options

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

Report: Too few staff to care for children admitted to intensive care units

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

Scientists reveal that human brain can trigger random behavior

FDA grants multiple Orphan Drug Designations for CytRx's aldoxorubicin

Research points to remote monitoring as offering way to improve patient care

Early detection of cancers on the horizon with supersensitive nanodevice

Scientists discover mechanism that resists cancer drugs in estrogen-positive breast cancer

Coffee consumption associated with increase in life years, reduction in healthcare costs

ED more prevalent than previously thought

New report urges nations to adopt improved data collection efforts for community health workers

Perfectionists may be at increased risk of suicide, says York University psychology professor

Researchers create new Cas9 animal model for in vivo genome editing experiments

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

Lung-MAP, ALCHEMIST clinical trials offer innovative study designs for lung cancer patients

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News